KRAS, p53 and BRAF gene mutations and aneuploidy in sporadic colorectal cancer progression

Cellular Oncology

Volumn 28, Issue 4, 2006, Pages 161-166

  Calistri, Daniele ^a   Rengucci, Claudia ^a   Seymour, Ian ^a   Leonardi, Elena ^b   Truini, Mauro ^c   Malacarne, Davide ^c   Castagnola, Patrizio ^c   Giaretti, Walter ^c  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Aneuploidy; Colorectal cancer; Gene mutations

Indexed keywords

B RAF KINASE; K RAS PROTEIN; PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER GROWTH; CASE STUDY; CHROMOSOMAL INSTABILITY; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33748896397     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. D.G. Albertson, C. Collins, F. McCormick and J.W. Gray, Chromosome aberrations in solid tumors, Nat. Genet. 34 (2003), 369-376.
2. H.J. Andreyev, A.R. Norman, D. Cunningham, J. Oates, B.R. Dix, B.J. Iacopetta, J. Young, T. Walsh, R. Ward, N. Hawkins, M. Beranek, P. Jandik, R. Benamouzig, E. Jullian, P. Laurent-Puig, S. Olschwang, O. Muller, I. Hoffmann, H.M. Rabes, C. Zietz, C. Troungos, C. Valavanis, S.T. Yuen, J.W. Ho, C.T. Croke, D.P. O'Donoghue, W. Giaretti, A. Rapallo, A. Russo, V. Bazan, M. Tanaka, K. Omura, T. Azuma, T. Ohkusa, T. Fujimori, Y. Ono, M. Pauly, C. Faber, R. Glaesener, A.F. de Goeij, J.W. Arends, S.N. Andersen, T. Lovig, J. Breivik, G. Gaudernack, O.P. Clausen, P.D. De Angelis, G.I. Meling, T.O. Rognum, R. Smith, H.S. Goh, A. Font, R. Resell, X.F. Sun, H. Zhang, J. Benhattar, L. Losi, J.Q. Lee, S.T. Wang, P.A. Clarke, S. Bell, P. Quirke, V.J. Bubb, J. Piris, N.R. Cruickshank, D. Morton, J.C. Fox, F. Al-Mulla, N. Lees, C.N. Hall, D. Snary, K. Wilkinson, D. Dillon, J. Costa, V.E. Pricolo, S.D. Finkelstein, J.S. Thebo, A.J. Senagore, S.A. Halter, S. Wadler, S. Malik, K. Krtolica and N. Urosevic, Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study, Br. J. Cancer 85 (2001), 692-696.
3. G. Auer, U. Kronenwett, U. Roblick, B. Franzén, J. Habermann, R. Sennerstam and T. Ried, Human breast adenocarcinoma: DNA content, chromosomes, gene expression and prognosis, Cell. Oncol. 26 (2004), 171-174.
4. M.S. Brose, P. Volpe, M. Feldman, M. Kumar, I. Rishi, R. Gerrero, E. Einhorn, M. Herlyn, J. Minna, A. Nicholson, J.A. Roth, S.M. Albelda, H. Davies, C. Cox, G. Brignell, P. Stephens, P.A. Futreal, R. Wooster, M.R. Stratton and B.L. Weber, BRAF and RAS mutations in human lung cancer and melanoma, Cancer Res. 62 (2002), 6997-7000.
5. D. Calistri, C. Rengucci, I. Seymour, A. Lattuneddu, A.M. Polifemo, F. Monti, L. Saragoni and D. Amadori, Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression, J. Cell. Physiol. 204 (2005), 484-488.
6. P. Castagnola and W. Giaretti, Mutant KRAS, chromosomal instability and prognosis in colorectal cancer, Biochim. Biophys. Acta 1756 (2005), 115-125.
7. T.L. Chan, W. Zhao, S.Y. Leung and S.T. Yuen, Cancer Genome Project: BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas, Cancer Res. 63 (2003), 4878-4881.
8. P. Duesberg, R. Li, D. Rasnick, A. Fabarius and R. Hehlmann, Carcinogenesis by aneuploidization. Cell. Oncol. 26 (2004), 181-186.
9. E.R. Fearon and B. Vogelstein, A genetic model for colorectal tumorigenesis, Cell 61 (1990), 759-767.
10. R. Fodde, R. Smits and H. Clevers, APC, signal transduction and genetic instability in colorectal cancer, Nat. Rev. Cancer 1 (2001), 55-67.
11. K. Fransen, M. Klintenas, A. Osterstrom, J. Dimberg, H.J. Monstein and P. Soderkvist, Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas, Carcinogenesis 25 (2004), 527-533.
12. W. Giaretti, S. Molinu, J. Ceccarelli and C. Prevosto, Chromosomal instability, aneuploidy, and gene mutations in human sporadic colorectal adenomas, Cell. Oncol. 26 (2004), 301-305.
13. W. Giaretti, N. Pujic, A. Rapallo, S. Nigro, A. Di Vinci, E. Geido and M. Risio, K-ras2 G-C and G-T transversions correlate with DNA aneuploidy in colorectal adenomas, Gastroenterology 108 (1995), 1040-1047.
14. W. Giaretti, T. Venesio, A. Sciutto, C. Prevosto, E. Geido and M. Risio, Near-diploid and near-triploid human sporadic colorectal cancer adenocarcinoma differ for KRAS2 and TP53 mutational status, Genes Chrom. Cancer 37 (2003), 207-213.
15. M. Hermsen, C. Postma, J. Baak, M. Weiss, A. Rapallo, A. Sciutto, G. Roemen, J.W. Arends, R. Williams, W. Giaretti, A. De Goeij and G. Meijer, Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability, Gastroenterology 123 (2002), 1109-1119.
16. B. Iacopetta, TP53 mutation in colorectal cancer, Hum. Mutat. 21 (2003), 271-276.
17. G.J.P.L. Kops, B.A.A. Weaver and D.W. Cleveland, On the road to cancer aneuploidy and the mitotic checkpoint, Nature Rev. Cancer 5 (2005), 773-785.
18. A. Leslie, N.R. Pratt, K. Gillespie, M. Sales, N.M. Kernohan, G. Smith, C.R. Wolf, F.A. Carey and R.J. Steele, Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas, Cancer Res. 63 (2003), 4656-4661.
19. A. Leslie, A. Stewart, D.U. Baty, D. Mechan, L. McGreavey, G. Smith, C.R. Wolf, M. Sales, N.R. Pratt, R.J. Steele and F.A. Carey, Chromosomal changes in colorectal adenomas: relationship to gene mutations and potential for clinical utility, Genes Chromosomes Cancer 45 (2006), 126-135.
20. F. Michor, Y. Iwasa and M.A. Nowak, Dynamics of cancer progression, Nat. Rev. Cancer 4 (2004), 197-205.
21. T. Nedergaard, P. Guldberg, E. Ralfkler and J. Zeuthen, A one-step DGGE scanning method for detection of mutations in the K-, N- and H-ras oncogenes: mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphoma, Int. J. Cancer 71 (1997), 364-369.
22. C.D. O' Connell, D.H. Atha, M.C. Oldemburg, J. Tian, M. Siebert, R. Handrow, K. Grooms, L. Heisler and M. de Arruda, Detection of p53 gene mutation: analysis by single-strand conformation polymorphism and cleavase fragment length polymorphism, Electrophoresis 20 (1999), 1211-1223.
23. M.G. Ormerod, B. Tribukait and W. Giaretti, Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology, Anal. Cell. Pathol. 17 (1998), 103-110.
24. I. Petersen, Chromosome, ploidy and genetic imbalances of lung cancer, Cell. Oncol. 26 (2004), 173-174.
25. W.S. Samowitz, C. Sweeney, J. Herrick, H. Albertsen, T.R. Levin, M.A. Murtaugh, R.K. Wolff and M.L. Slattery, Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers, Cancer Res. 65 (2005), 6063-6069.
26. S. Sengupta and C.C. Harris, p53: traffic cop at the crossroads of DNA repair and recombination, Nat. Rev. Mol. Cell. Biol. 6 (2005), 44-55.
27. I.M. Shih, W. Zhou, S.N. Goodman, C. Lengauer, K.W. Kinzler and B. Vogelstein, Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis, Cancer Res. 61 (2001), 818-822.
28. G. Smith, F.A. Carey, J. Beattie, M.J. Wilkie, T.J. Lightfoot, J. Coxhead, R.C. Garner, R.J. Steele and C.R. Wolf, Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer, Proc. Natl. Acad. Sci. USA 99 (2002), 9433-9438.
29. F. Sommerer, M. Vieth, A. Markwarth, K. Rohrich, S. Vomschloss, A. May, C. Ell, M. Stolte, U.R. Hengge, C. Wittekind and A. Tannapfel, Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma, Oncogene 23 (2004), 554-558.
30. R. Soong, B. Powell, H. Elsaleh, G. Gnanasampanthan, D.R. Smith, H.S. Goh, D. Joseph and B. Iacopetta, Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation, Eur. J. Cancer 36 (2000), 2053-2060.
31. Z. Wang, J.M. Cummins, D. Shen, D.P. Cahill, P.V. Jallepalli, T.L. Wang, D.W. Parsons, G. Traverso, M. Awad, N. Silliman, J. Ptak, S. Steve Szabo, J.K.V. Willson, S.D. Markowitz, M.L. Goldberg, R. Karess, K.W. Kinzler, B. Vogelstein, V.E. Velculescu and C. Lengauer, Three classes of genes mutated in colorectal cancers with chromosomal instability, Cancer Res. 64 (2004), 2998-3001.
32. L. Wang, J.M. Cunningham, J.L. Winters, J.C. Guenther, A.J. French, L.A. Boardman, L.J. Burgart, S.K. McDonnell, D.J. Schaid and S.N. Thibodeau, BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair, Cancer Res. 63 (2003), 5209-5212.
33. S.T. Yuen, H. Davies, T.L. Chan, J.W. Ho, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, W.W. Tsui, A.S. Chan, P.A. Futreal, M.R. Stratton, R. Wooster and S.Y. Leung, Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia, Cancer Res. 62 (2002), 6451-6455.